Suppr超能文献

STAT3 转录因子促进急性移植物抗宿主病期间 nTreg 细胞的不稳定性,并限制 iTreg 细胞的生成。

STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.

机构信息

Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Immunity. 2012 Aug 24;37(2):209-22. doi: 10.1016/j.immuni.2012.05.027.

Abstract

Acute graft-versus-host disease (GvHD) is a major cause of mortality in allogeneic bone marrow transplantation (BMT), for which administration of FoxP3(+) regulatory T (Treg) cells has been proposed as a therapy. However, the phenotypic stability of Treg cells is controversial, and STAT3-dependent cytokines can inhibit FoxP3 expression. We assessed whether the elimination of STAT3 in T cells could limit the severity of GvHD. We found STAT3 limited FoxP3(+) Treg cell numbers following allogeneic BMT by two pathways: instability of natural Treg (nTreg) cells and inhibition of induced Treg (iTreg) cell polarization from naive CD4(+) T cells. Deletion of STAT3 within only the nTreg cell population was not sufficient to protect against lethal GvHD. In contrast, transfer of STAT3-deficient naive CD4(+) T cells increased FoxP3(+) Treg cells post-BMT and prevented lethality, suggesting that the consequence of STAT3 signaling may be greater for iTreg rather than nTreg cells during GvHD.

摘要

急性移植物抗宿主病 (GvHD) 是异基因骨髓移植 (BMT) 患者死亡的主要原因,已有研究提出,FoxP3(+)调节性 T (Treg) 细胞的输注可能是一种有效的治疗方法。然而,Treg 细胞的表型稳定性存在争议,STAT3 依赖性细胞因子可抑制 FoxP3 的表达。我们评估了 T 细胞中 STAT3 的缺失是否可以限制 GvHD 的严重程度。我们发现,在异基因 BMT 后,STAT3 通过两种途径限制 FoxP3(+)Treg 细胞的数量:天然 Treg(nTreg)细胞的不稳定性和初始 CD4(+)T 细胞向诱导性 Treg(iTreg)细胞极化的抑制。仅在 nTreg 细胞群中缺失 STAT3 不足以预防致死性 GvHD。相比之下,STAT3 缺陷的初始 CD4(+)T 细胞的转移增加了 BMT 后 FoxP3(+)Treg 细胞的数量,并预防了致死性,这表明在 GvHD 期间,STAT3 信号的后果可能对 iTreg 细胞比对 nTreg 细胞更大。

相似文献

2
Instability of Foxp3 expression limits the ability of induced regulatory T cells to mitigate graft versus host disease.
Clin Cancer Res. 2011 Jun 15;17(12):3969-83. doi: 10.1158/1078-0432.CCR-10-3347. Epub 2011 May 10.
7
CD8+ Foxp3+ regulatory T cells are induced during graft-versus-host disease and mitigate disease severity.
J Immunol. 2012 Jul 1;189(1):464-74. doi: 10.4049/jimmunol.1200886. Epub 2012 May 30.
8
Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.
Biol Blood Marrow Transplant. 2011 Mar;17(3):309-18. doi: 10.1016/j.bbmt.2010.12.710. Epub 2011 Jan 9.

引用本文的文献

1
PD-1 receptor deficiency enhances CD30 T cell function in melanoma.
Nat Immunol. 2025 Jun 2. doi: 10.1038/s41590-025-02172-0.
2
[Effects of donor T cell stat3 deficiency on acute intestinal graft-versus-host disease in mice].
Zhonghua Xue Ye Xue Za Zhi. 2025 Apr 14;46(4):302-313. doi: 10.3760/cma.j.cn121090-20250107-00011.
3
Evaluating Axatilimab as a treatment option for chronic graft-versus-host disease.
Immunotherapy. 2025 Apr;17(6):409-418. doi: 10.1080/1750743X.2025.2501928. Epub 2025 May 8.
5
The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs.
Cell Mol Immunol. 2025 May;22(5):541-556. doi: 10.1038/s41423-025-01281-y. Epub 2025 Apr 7.
6
ROS-dependent SOCS3 upregulation disrupts regulatory T cell stability during autoimmune disease development.
Redox Biol. 2025 May;82:103590. doi: 10.1016/j.redox.2025.103590. Epub 2025 Mar 10.
7
The TET-TDG axis in T cells and biological processes.
Int Immunol. 2025 May 21;37(6):299-312. doi: 10.1093/intimm/dxaf006.
8
Targeting p97-Npl4 interaction inhibits tumor T cell development to enhance tumor immunity.
Nat Immunol. 2024 Sep;25(9):1623-1636. doi: 10.1038/s41590-024-01912-y. Epub 2024 Aug 6.
9
IFNγ Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy.
Cancer Res Commun. 2024 Aug 1;4(8):2045-2057. doi: 10.1158/2767-9764.CRC-23-0500.
10
STAT activation in regulatory CD4 T cells of patients with primary sclerosing cholangitis.
Immun Inflamm Dis. 2024 Apr;12(4):e1248. doi: 10.1002/iid3.1248.

本文引用的文献

2
CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.
J Mol Cell Biol. 2012 Feb;4(1):11-21. doi: 10.1093/jmcb/mjr047. Epub 2011 Dec 14.
3
IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.
J Immunol. 2011 Jun 1;186(11):6329-37. doi: 10.4049/jimmunol.1100061. Epub 2011 Apr 27.
6
Regulatory T cells: history and perspective.
Methods Mol Biol. 2011;707:3-17. doi: 10.1007/978-1-61737-979-6_1.
7
Signal transduction pathways and transcriptional regulation in Th17 cell differentiation.
Cytokine Growth Factor Rev. 2010 Dec;21(6):425-34. doi: 10.1016/j.cytogfr.2010.10.006. Epub 2010 Nov 16.
8
Stability of the regulatory T cell lineage in vivo.
Science. 2010 Sep 24;329(5999):1667-71. doi: 10.1126/science.1191996.
10
Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis.
Immunity. 2010 May 28;32(5):605-15. doi: 10.1016/j.immuni.2010.05.003. Epub 2010 May 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验